Zoliflodacin Patent Expiration
Zoliflodacin was first introduced by Entasis Therapeutics Inc
Zoliflodacin Patents
Given below is the list of patents protecting Zoliflodacin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Nuzolvence | US8889671 | Compounds And Methods For Treating Bacterial Infections | Jan 21, 2034 | Entasis Therap |
| Nuzolvence | US9187495 | Compounds And Methods For Treating Bacterial Infections | Jan 21, 2034 | Entasis Therap |
| Nuzolvence | US9540394 | Compounds And Methods For Treating Bacterial Infections | Jan 21, 2034 | Entasis Therap |
| Nuzolvence | US9839641 | Compounds And Methods For Treating Bacterial Infections | Jan 21, 2034 | Entasis Therap |
| Nuzolvence | US8658641 | Fused, Spirocyclic Heteroaromatic Compounds For The Treatment Of Bacterial Infections | Jun 20, 2030 | Entasis Therap |
| Nuzolvence | US9040528 | Chemical Compounds 542 | Oct 13, 2029 | Entasis Therap |
Zoliflodacin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List